Needle-Free Injection Systems Market Growth Forecast 2024-2028

The Global needle-free injection systems market is projected to grow by USD 20.15 billion from 2024 to 2028, at a CAGR of 16.83%. Market growth is driven by the increasing demand for minimally invasive medical procedures, the integration of AI, telecare, e-prescription, and sterility assurance technologies, and the need to reduce needlestick injuries (NSIs). Stringent medical device regulations further ensure the adoption of safe and efficient solutions.

For more details about the industry, get the PDF sample report for free

Market Segmentation

By End-User

• Hospitals and Clinics
• Home Care Settings
• Research Laboratories

By Product

• Fillable
• Pre-Filled

By Region

North America

• United States

• Canada

Europe

• Germany

• United Kingdom

Asia

• China

Rest of the World (ROW)

North America is expected to contribute 42% to global market growth, with the United States driving demand. The market in the US is supported by factors such as insurance coverage, R&D investments, an aging population with chronic diseases, and rising needlestick injuries (NSIs). According to the National Center for Biotechnology Information (NCBI), around six million NSIs occur annually in the US, increasing the demand for self-administered drugs and safe injectable technologies. States such as Indiana, Ohio, and Illinois are seeing strong market growth due to advanced medical infrastructure and an increasing number of diagnostic laboratories.

Market Dynamics

Market Drivers

• Growing preference for minimally invasive biopsies
• Rising demand for self-injection devices in chronic disease management (e.g., diabetes, HIV/AIDS, cancer)
• Increasing adoption of microarray patches, liquid-based injectors, and powder-based injectors for vaccine and biologics delivery
• Expansion of needle-free injection systems in hospitals, home care, and research laboratories

Market Trends

• Rising incidence of needlestick infections (NSIs) driving demand for safer alternatives
• Advancements in AI, telecare, e-prescription, and sterility assurance technologies enhancing device performance
• Growth in mass vaccination programs and home care applications

Market Challenges

• Stringent medical device regulations requiring clinical trials and FDA approvals
• High development costs associated with Class III medical devices
• Compliance challenges in self-injection technology adoption

Get more details by ordering the complete report

Key Players

• Aijex Pharma International Inc.
• AKRA DERMOJET
• Amico Group
• ANTARES PHARMA INC.
• Becton Dickinson and Co.
• Crossject
• Endo International Plc
• Ferring BV
• Inovio Pharmaceuticals Inc.
• Lepu Medical Technology Beijing Co. Ltd.
• Medbitz Pte Ltd.
• Mika Medical Co.
• Needle Free Injection System
• NuGen Medical Devices
• PharmaJet Inc.
• PORTAL INSTRUMENTS INC.
• QUINOVARE and TECHiJET
• Recipharm AB
• Technologies Médicales Internationales Inc.
• West Pharmaceutical Services Inc.

Future Market Insights

The needle-free injection systems market is poised for strong growth, supported by increasing demand for minimally invasive medical solutions, chronic disease management, and mass vaccination programs. Innovations in AI-driven drug delivery systems and regulatory advancements will further shape market expansion.